In addition, studies that establish the effectiveness of CABG in comparison with contemporary GDMT are necessary, as are studies that better define the relative benefits of different revascularization techniques (Figure 13). Presidents and Staff American College of Cardiology Foundation William A. Zoghbi, MD, FACC, President Thomas E. Arend, Jr. Esq, CAE, Interim Chief Staff Officer William J. Oetgen, MD, MBA, FACC, Senior Vice President, Science and Quality Charlene L. May, Senior Director, Science and Clinical Policy Erin A. Barrett, MPS, Senior Specialist, Science and Clinical Policy American College of Cardiology Foundation/American Heart Association Lisa Bradfield, CAE, Director, Science and Clinical Policy Maria Koinis, Specialist, Science and Clinical Policy Sue Keller, BSN, MPH, Senior Specialist, Evidence-Based Medicine American Heart Association Gordon F. Tomaselli, MD, FAHA, President Nancy Brown, Chief Executive Officer Rose Marie Robertson, MD, FAHA, Chief Science Officer Gayle R. Whitman, PhD, RN, FAHA, FAAN, Senior Vice President, Office of Science Operations Judy L. Bezanson, DSN, RN, CNS-MS, FAHA, Science and Medicine Advisor, Office of Science Operations References 1. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. 2012. Availableat:http://assets.cardiosource.com/Methodology_Manual_for_ACC_ AHA_Writing_Committees.pdf and http://my.americanheart.org/idc/groups/ ahamah-public/@wcm/sop/documents/downloadable/ucm_319826.pdf. Accessed May 16, 2012. 2. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008;117:296 329. 3. Kushner FG, Hand M, Smith SC Jr, et al. 